Psychedelics Archives - Page 34 of 68

2 minute read

Psilocybin Therapy Continues To Show Positive Outcomes For Cancer And Major Depression Disorder

April 14, 7:04 PM

Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published in the acclaimed JAMA Oncology.

CMPS

2 minute read

Numinus Q2 2023: 581% Revenue Growth, 820% In Gross Profit And Strong Cash Position

By Lara Goldstein

April 14, 2:58 PM

Psychedelics mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) announced its financial results for the three and six months ended Feb. 28, 2023. Q2 numbers show: Total cash of $14.7 (CA$19.7) million as of Feb. 28, 2023.

NUMIF

1 minute read

Awakn’s Psychedelics Medical Chief Steps Down, Shifts In Company’s Stocks And Ownership

By Lara Goldstein

April 14, 12:24 PM

Awakn Life Sciences Corp. (OTCQB: AWKNF), the biotech company developing psychedelic therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD) shared its recent corporate news.

AWKNF

3 minute read

EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga’s Psychedelics Capital Conference

By Lara Goldstein

April 14, 11:36 AM

At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the industry.

RVLWF

3 minute read

EXCLUSIVE: Infrastructure Built For Healing: ‘Consolidation And Legitimacy Are Crucial For Psychedelic Industry Growth’

By Joana Scopel

April 13, 7:22 PM

“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB:

NUMIF

2 minute read

This Online Training To Facilitate A Psychedelic Therapy Is Free – Check Out Cybin’s New Offer

By Lara Goldstein

April 12, 5:31 PM

Cybin Inc. (NYSE: CYBN), a clinical-stage biopharma company developing innovative psychedelic-based treatment options, is launching a free online facilitation training course.

CYBN

2 minute read

Joint Venture Partnership Expands Access To Psychedelics Therapy For Some 50K Patients

By Lara Goldstein

April 12, 4:19 PM

Ketamine clinics operator Revitalist Lifestyle & Wellness Ltd. (OTCQB: RVLWF) and psilocybin bioscience and wellness platforms company Wake Network have partnered with GCM Partners LLC to offer new ketamine treatment locations in two facilities in Chicago, two in Orlando and one in Miami.

RVLWF

2 minute read

Check Out The Canadian Company Building On Several Vertical Psychedelics Businesses

By Lara Goldstein

April 12, 1:52 PM

Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF)’s new clinic licensing model, The Numinus Network offers independent practitioners the chance to own and operate their own clinic under the Numinus brand through a licensing and services arrangement.

NUMIF